July 2026
The global infectious disease vaccines market size is estimated to hit around USD 77.04 billion by 2035 increasing from USD 38.83 billion in 2025, with a CAGR of 7.09%.
May 2026
The infectious respiratory disease diagnostics market size is projected to hit around USD 96.57 billion by 2035 from USD 57.55 billion in 2025 with a CAGR of 5.31%.
March 2026
The global infectious disease immunoassay market size was evaluated at USD 2.88 billion in 2025 and is predicted to hit around USD 8.87 billion by 2035, growing at a CAGR of 11.90%.
March 2026
The global infectious disease diagnostics market size is expected to reach around USD 71.06 billion by 2035 from USD 35.39 billion in 2025 with a CAGR of 7.22%.
January 2026
The infectious disease in-vitro diagnostics market size is valued at USD 28.10 billion in 2025 and is expected to hit around USD 35.68 billion by 2035, growing at a CAGR of 2.42%.
January 2026
The global point-of-care infectious disease diagnostics market size is projected to hit around USD 25.66 billion by 2035, with a CAGR of 15.26% from 2026 to 2035.
November 2025
The infectious disease therapeutics market size is calculated at USD 36.22 billion in 2025 and is expected to hit around USD 53.48 billion by 2035 at a CAGR of 3.97%.
August 2025
The global antibody ELISA kits for tropical infectious disease market size was valued at USD 2.39 billion in 2024 and is expected to hit around USD 4.41 billion by 2034, growing at a CAGR of 6.32%.
July 2025
The global infectious disease molecular diagnostics market size is estimated to hit around USD 63.37 billion by 2034 with a CAGR of 3.25% from 2025 to 2034.
January 2025
The U.S. point of care infectious disease testing market size is projected to hit around USD 5.27 billion by 2035, growing at a CAGR of 8.98% from 2026 to 2035.
July 2026
The lyme disease diagnostic devices market size accounted for USD 2.82 billion in 2025 and is predicted to hit around USD 4.79 billion by 2035, with a CAGR of 5.44%.
July 2026
The global pneumococcal vaccines market size was evaluated at 9.04 billion in 2025 and is predicted to hit around USD 16.68 billion by 2035, growing at a CAGR of 6.32%.
July 2026
The orphan disease biomarkers market expands with advancements in genomics, proteomics, and bioinformatics for rare conditions.
June 2026
The rare disease small-batch CDMO market is expanding with demand for specialized manufacturing of orphan drugs and niche therapies.
June 2026
The global celiac disease treatment market size is evaluated at USD 784.59 million in 2025 and is predicted to hit around USD 2,400.49 million by 2035, growing at a CAGR of 11.83%.
June 2026
The global non-alcoholic fatty liver disease (NAFLD) drug market size is estimated to hit around USD 35.10 billion by 2035 from USD 21.98 billion in 2025, with a CAGR of 4.79%.
June 2026
The global feline vaccines market size is estimated to hit around USD 3.49 billion by 2035 increasing from USD 1.77 billion in 2025, with a CAGR of 7.02%.
June 2026
The global minimal residual disease (MRD) testing market size is estimated to hit around USD 5.19 billion by 2035 increasing from USD 1.70 billion in 2025, with a CAGR of 11.81%.
June 2026
The global chronic disease management market size was estimated at USD 6.61 billion in 2025 and is expected to hit around USD 23.18 billion by 2035, growing at a CAGR of 13.37% from 2026 to 2035.
June 2026
The global neurological rare disease biologics market is growing as advanced biologics address unmet needs in rare neurological disorders.
June 2026
The RNA editing for neurodegenerative diseases market is growing as advanced RNA technologies target conditions like Alzheimer’s and Parkinson’s.
June 2026
The mRNA vaccines and therapeutics market size reached USD 116.88 billion in 2025 and is projected to surpass around USD 297.84 billion by 2035 with a CAGR of 9.81%.
June 2026
The rare diseases treatment market size was estimated at USD 244.57 billion in 2025 and is predicted to hit around USD 566.83 billion by 2035 with a CAGR of 8.77%.
June 2026
The global Huntingtons disease market size was evaluated at USD 1.42 billion in 2025 and is predicted to hit around USD 6.48 billion by 2035, growing at a CAGR of 17.20%.
June 2026
The global sickle cell disease treatment market size is predicted to hit around USD 15.81 billion by 2035 from USD 3.75 billion in 2025 with a CAGR of 15.48%.
June 2026
The global adult vaccines market size was evaluated at USD 19.97 billion in 2025 and is predicted to hit around USD 50.39 billion by 2035, growing at a CAGR of 9.70%.
May 2026
The global disease management apps market size is calculated at USD 10.20 billion in 2025 and is projected to hit around USD 27 billion by 2035 with a CAGR of 10.22%.
May 2026
The global diabetic kidney disease market size was valued at USD 3.25 billion in 2025 and is projected to hit around USD 5.23 billion by 2035 with a CAGR of 4.87%.
May 2026
The global graves disease (overactive thyroid) market size is estimated to hit around USD 3.69 billion by 2035 increasing from USD 2.26 billion in 2025, with a CAGR of 5.02%.
May 2026
The global Alzheimers disease diagnostics market size was evaluated at USD 9.40 billion in 2025 and is predicted to hit around USD 26.21 billion by 2035, growing at a CAGR of 10.80%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com